• Monday, Oct 26, 2020
  • Last Update : 10:13 am

India begins selecting people for priority Covid-19 vaccines

  • Published at 05:08 pm October 17th, 2020
COvid-19 Vaccine Sputnik-V
File photo: Bottles with Russia's ‘Sputnik-V’ vaccine against the Covid-19 are seen before inoculation at a clinic, in Tver on October 12, 2020 Reuters

Health minister Harsh Vardhan had said that India hopes to receive up to 500 million doses of Covid-19 vaccines by July next year to inoculate about 250 million people

India’s coronavirus infections rose by another 62,212 cases over the previous day and a local media report said on Saturday that the government had begun identifying about 300 million people who would be given the vaccine first when it is ready.

The Times of India said that frontline health and sanitation workers, police officials and elderly people with co-morbidities will get the vaccine on priority.

The plan, which is still in the draft stage, aims to cover 23% of the population in the first phase. The final plan is likely to be ready by end October-November, the report said.

The selected individuals will be given an estimated 600 million doses.

Earlier this month, health minister Harsh Vardhan had said that India hopes to receive up to 500 million doses of coronavirus vaccines by July next year to inoculate about 250 million people.

Officials have said that giving the vaccine to India’s 1.3 billion people will be a mammoth exercise, likely to stretch well into 2022.

India's cumulative tally of coronavirus infections stood at 7.43 million on Saturday, having risen by 62,212 in the last 24 hours, health ministry data showed.

But the number of active infections slipped below 800,000 for the first time in 1.5 months, which the ministry called a significant achievement.

India has recorded the world's second-largest number of cases after the United States and worries have been high that there may be further spikes during the ongoing festival season.

Renewed approval for Russia

The Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories Ltd have received renewed approval to conduct late-stage clinical trials in India of the Russian Covid-19 vaccine, the sovereign wealth fund said on Saturday.

Large-scale trials of the Sputnik V vaccine in India were first announced and then knocked back by Indian regulators, who said the scale of Phase I and II trials conducted in Russia earlier this year was too small, requesting that they be repeated.

Following a new agreement, India will now carry out an adaptive phase II and III human clinical trial involving 1,500 participants, RDIF, which is marketing the vaccine abroad, said on Saturday.

Under the deal, Dr Reddy's will conduct the clinical trials and, subject to approval, distribute the finished vaccine in India. RDIF will supply 100 million doses to Dr Reddy's.

RDIF has reached agreements with Indian manufacturers to produce 300 million doses of the shot.

Russia has also reached an agreement with the biotechnology department of India's Science and Technology Ministry to use its laboratories as a base for the Indian clinical trial, the source said.

54
52
blogger sharing button blogger
buffer sharing button buffer
diaspora sharing button diaspora
digg sharing button digg
douban sharing button douban
email sharing button email
evernote sharing button evernote
flipboard sharing button flipboard
pocket sharing button getpocket
github sharing button github
gmail sharing button gmail
googlebookmarks sharing button googlebookmarks
hackernews sharing button hackernews
instapaper sharing button instapaper
line sharing button line
linkedin sharing button linkedin
livejournal sharing button livejournal
mailru sharing button mailru
medium sharing button medium
meneame sharing button meneame
messenger sharing button messenger
odnoklassniki sharing button odnoklassniki
pinterest sharing button pinterest
print sharing button print
qzone sharing button qzone
reddit sharing button reddit
refind sharing button refind
renren sharing button renren
skype sharing button skype
snapchat sharing button snapchat
surfingbird sharing button surfingbird
telegram sharing button telegram
tumblr sharing button tumblr
twitter sharing button twitter
vk sharing button vk
wechat sharing button wechat
weibo sharing button weibo
whatsapp sharing button whatsapp
wordpress sharing button wordpress
xing sharing button xing
yahoomail sharing button yahoomail